141 related articles for article (PubMed ID: 11436282)
61. Mesalazine for the treatment of inflammatory bowel disease.
Criscuoli V; Modesto I; Orlando A; Cottone M
Expert Opin Pharmacother; 2013 Aug; 14(12):1669-78. PubMed ID: 23767798
[TBL] [Abstract][Full Text] [Related]
62. Saccharomyces boulardii in maintenance treatment of Crohn's disease.
Guslandi M; Mezzi G; Sorghi M; Testoni PA
Dig Dis Sci; 2000 Jul; 45(7):1462-4. PubMed ID: 10961730
[TBL] [Abstract][Full Text] [Related]
63. Prevention of relapse by mesalazine (Pentasa) in pediatric Crohn's disease: a multicenter, double-blind, randomized, placebo-controlled trial.
Cezard JP; Munck A; Mouterde O; Morali A; Lenaerts C; Lachaux A; Turck D; Schmitz J; Maurage C; Girardet JP; Belli D; Lamireau T; Sarles J; Chouraqui JP; Descos B; Dabadi A; Meyer M; Olives JP; Mary JY
Gastroenterol Clin Biol; 2009 Jan; 33(1 Pt 1):31-40. PubMed ID: 19118966
[TBL] [Abstract][Full Text] [Related]
64. Mesalazine as a maintenance treatment in Crohn's disease: is it the long awaited solution?
Sahmoud T; Mary JY; Sahmoud T
Gut; 1997 Feb; 40(2):284-5. PubMed ID: 9071946
[No Abstract] [Full Text] [Related]
65. Effectiveness of Mesalazine, Thiopurines and Tumour Necrosis Factor Antagonists in Preventing Post-Operative Crohn's Disease Recurrence in a Real-Life Setting.
Allocca M; Landi R; Bonovas S; Fiorino G; Papa A; Spinelli A; Furfaro F; Peyrin-Biroulet L; Armuzzi A; Danese S
Digestion; 2017; 96(3):166-172. PubMed ID: 28903094
[TBL] [Abstract][Full Text] [Related]
66. Rectal perforation caused by mesalazine enema in a patient with ulcerative colitis.
Kume K; Watanabe T; Oshima J; Yoshikawa I; Harada M
Endoscopy; 2014; 46 Suppl 1 UCTN():E190. PubMed ID: 24756289
[No Abstract] [Full Text] [Related]
67. 5-ASA therapy for active Crohn's disease: old friends, old data, and a new conclusion.
Feagan BG
Clin Gastroenterol Hepatol; 2004 May; 2(5):376-8. PubMed ID: 15118974
[No Abstract] [Full Text] [Related]
68. Review article: medical treatment of mild to moderately active Crohn's disease.
Löfberg R
Aliment Pharmacol Ther; 2003 Jun; 17 Suppl 2():18-22. PubMed ID: 12786608
[TBL] [Abstract][Full Text] [Related]
69. A comparison of budesonide and mesalamine for active Crohn's disease. International Budesonide-Mesalamine Study Group.
Thomsen OO; Cortot A; Jewell D; Wright JP; Winter T; Veloso FT; Vatn M; Persson T; Pettersson E
N Engl J Med; 1998 Aug; 339(6):370-4. PubMed ID: 9691103
[TBL] [Abstract][Full Text] [Related]
70. Effects of mesalazine enemas on lymphoid follicular proctitis.
Liu Z; Huang S; Chen Z; Wang X
Rev Esp Enferm Dig; 2018 Sep; 110(9):591-593. PubMed ID: 29931988
[TBL] [Abstract][Full Text] [Related]
71. Aminosalicylates for induction of remission or response in Crohn's disease.
Lim WC; Hanauer S
Cochrane Database Syst Rev; 2010 Dec; (12):CD008870. PubMed ID: 21154400
[TBL] [Abstract][Full Text] [Related]
72. Granulomatous cheilitis and Crohn's disease in a 3-year-old boy.
Dummer W; Lurz C; Jeschke R; Meissner N; Rose C; Bröcker EB
Pediatr Dermatol; 1999; 16(1):39-42. PubMed ID: 10027998
[TBL] [Abstract][Full Text] [Related]
73. Combined oral and enema treatment with Pentasa (mesalazine) is superior to oral therapy alone in patients with extensive mild/moderate active ulcerative colitis: a randomised, double blind, placebo controlled study.
Marteau P; Probert CS; Lindgren S; Gassul M; Tan TG; Dignass A; Befrits R; Midhagen G; Rademaker J; Foldager M
Gut; 2005 Jul; 54(7):960-5. PubMed ID: 15951542
[TBL] [Abstract][Full Text] [Related]
74. Prophylaxis of postoperative relapse in Crohn's disease with mesalamine: European Cooperative Crohn's Disease Study VI.
Lochs H; Mayer M; Fleig WE; Mortensen PB; Bauer P; Genser D; Petritsch W; Raithel M; Hoffmann R; Gross V; Plauth M; Staun M; Nesje LB
Gastroenterology; 2000 Feb; 118(2):264-73. PubMed ID: 10648454
[TBL] [Abstract][Full Text] [Related]
75. Acute renal failure in a 53-year-old woman with Crohn's disease treated with 5-aminosalicylic acid.
Haas M; Shetye KR
Am J Kidney Dis; 2001 Jul; 38(1):205-9. PubMed ID: 11431204
[No Abstract] [Full Text] [Related]
76. Crohn's disease and secondary amyloidosis: early complication? A case report and review of the literature.
Basturk T; Ozagari A; Ozturk T; Kusaslan R; Unsal A
J Ren Care; 2009 Sep; 35(3):147-50. PubMed ID: 19689697
[TBL] [Abstract][Full Text] [Related]
77. Chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease.
Bauditz J; Lochs H; Schreiber S
N Engl J Med; 1998 Jan; 338(5):334. PubMed ID: 9446035
[No Abstract] [Full Text] [Related]
78. Budesonide versus mesalamine for maintaining remission in patients refusing other immunomodulators for steroid-dependent Crohn's disease.
Mantzaris GJ; Petraki K; Sfakianakis M; Archavlis E; Christidou A; Chadio-Iordanides H; Triadaphyllou G
Clin Gastroenterol Hepatol; 2003 Mar; 1(2):122-8. PubMed ID: 15017504
[TBL] [Abstract][Full Text] [Related]
79. [Solitary ulcer of the rectum. Apropos of a case in childhood and review of bibliography].
Gallastegui Dañobeitia C; Trías i Folch E; Vilar i Escrigas P; Varea Calderón V; Amat Ballarín L; Medina Zurinaga M
An Esp Pediatr; 1987 Apr; 26(4):285-8. PubMed ID: 3300456
[TBL] [Abstract][Full Text] [Related]
80. Interstitial nephritis in children with Crohn's disease.
Benador N; Grimm P; Lemire J; Griswold W; Billman G; Reznik V
Clin Pediatr (Phila); 2000 Apr; 39(4):253-4. PubMed ID: 10791141
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
